Jonel Trebicka Selected Research

Transjugular Intrahepatic Portasystemic Shunt

6/2022	Aspirin improves transplant-free survival after TIPS implantation in patients with refractory ascites: a retrospective multicentre cohort study.
5/2022	Restoration of the gut microbiota is associated with a decreased risk of hepatic encephalopathy after TIPS.
5/2022	TIPS for the management of stomal variceal bleeding due to cirrhotic and non-cirrhotic portal hypertension.
3/2022	Preoperative TIPS prevents the development of postoperative acute-on-chronic liver failure in patients with high CLIF-C AD score.
1/2022	Cranial stent position is independently associated with the development of TIPS dysfunction.
12/2021	TIPS and splenorenal shunt for complications of portal hypertension in chronic hepatosplenic schistosomiasis-A case series and review of the literature.
9/2021	Lower Ratio of Liver Volume and Body Weight Is a Negative Predictor of Survival after Transjugular Intrahepatic Portosystemic Shunt.
8/2021	Glue Embolization of Gastroesophageal Varices during Transjugular Intrahepatic Portosystemic Shunt (TIPS) Improves Survival Compared to Coil-only Embolization-A Single-Center Retrospective Study.
7/2021	Elective Surgery but not Transjugular Intrahepatic Portosystemic Shunt Precipitates Acute-On-Chronic Liver Failure.
6/2021	Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonel Trebicka Research Topics

Disease

122	Fibrosis (Cirrhosis) 05/2022 - 06/2005
63	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 04/2008
58	Portal Hypertension 10/2022 - 06/2005
40	Inflammation (Inflammations) 01/2022 - 10/2010
36	Ascites 06/2022 - 04/2008
28	Acute-On-Chronic Liver Failure 05/2022 - 10/2017
27	Liver Diseases (Liver Disease) 01/2022 - 02/2015
23	Hemorrhage 06/2022 - 11/2011
20	Hepatic Encephalopathy 05/2022 - 02/2015
17	Infections 01/2022 - 12/2010
15	Thrombosis (Thrombus) 12/2021 - 01/2010
14	End Stage Liver Disease 05/2022 - 11/2011
12	Neoplasms (Cancer) 01/2022 - 08/2009
10	Bacterial Infections (Bacterial Infection) 04/2021 - 06/2013
9	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2017
6	Varicose Veins (Varicose Vein) 05/2022 - 01/2016
6	Peritonitis 01/2022 - 01/2017
6	Hepatorenal Syndrome 01/2022 - 01/2017
6	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 02/2004
6	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 02/2011 - 06/2005
5	Dysbiosis 05/2022 - 01/2018
5	Sarcopenia 01/2022 - 01/2018
5	Disease Progression 01/2022 - 01/2019
5	Liver Failure 12/2021 - 07/2015
4	Body Weight (Weight, Body) 09/2021 - 01/2017
4	Alcoholic Fatty Liver 01/2021 - 08/2015
4	Necrosis 01/2020 - 07/2011
3	Obesity 12/2021 - 03/2020
3	Weight Gain 10/2021 - 02/2004
3	Heart Failure 06/2021 - 08/2009
3	Alcoholic Hepatitis 01/2021 - 10/2016
3	Weight Loss (Weight Reduction) 01/2021 - 08/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 05/2017 - 06/2014
3	Hypotension (Low Blood Pressure) 06/2014 - 03/2006
2	Hepatitis C 10/2022 - 04/2012
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 08/2020
2	Acute Liver Failure (Fulminant Hepatic Failure) 01/2022 - 05/2010

Drug/Important Bio-Agent (IBA)

23	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2013
13	AlbuminsIBA 01/2022 - 08/2008
13	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2004
11	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2021 - 07/2007
10	BilirubinIBA 05/2022 - 05/2015
10	CytokinesIBA 04/2021 - 10/2010
9	Anti-Bacterial Agents (Antibiotics)IBA 08/2022 - 01/2018
9	Messenger RNA (mRNA)IBA 01/2022 - 01/2011
9	rho-Associated KinasesIBA 01/2019 - 03/2006
8	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2020 - 01/2015
7	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2015
7	Hydroxyproline (4 Hydroxyproline)IBA 01/2021 - 10/2010
6	CollagenIBA 01/2022 - 01/2011
6	LigandsIBA 01/2021 - 04/2012
5	Vasoconstrictor AgentsIBA 01/2022 - 03/2006
5	Complement C3 (C3 Complement)IBA 01/2021 - 01/2013
5	SodiumIBA 01/2020 - 06/2005
5	Angiotensin IIIBA 01/2017 - 06/2005
4	Transaminases (Aminotransferases)IBA 01/2022 - 01/2018
4	16S Ribosomal RNAIBA 01/2022 - 01/2019
4	Rifaximin (L 105)FDA Link 01/2022 - 02/2018
4	LipidsIBA 01/2022 - 01/2020
4	Alanine Transaminase (SGPT)IBA 12/2021 - 01/2015
4	BiglycanIBA 01/2021 - 01/2020
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2020 - 11/2011
4	CholesterolIBA 05/2017 - 08/2015
4	Atorvastatin (Lipitor)FDA Link 09/2015 - 07/2007
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2019
3	Apolipoproteins E (ApoE)IBA 01/2022 - 08/2015
3	AngiotensinsIBA 01/2022 - 10/2013
3	C-Reactive ProteinIBA 04/2021 - 12/2010
3	EnzymesIBA 01/2021 - 11/2019
3	Ethanol (Ethyl Alcohol)IBA 01/2021 - 07/2011
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 08/2015
3	InflammasomesIBA 01/2021 - 01/2021
3	oil red OIBA 01/2021 - 07/2011
3	ReninIBA 05/2020 - 01/2019
3	Pharmaceutical PreparationsIBA 01/2019 - 01/2017
3	CreatinineIBA 01/2019 - 01/2016
3	ChemokinesIBA 01/2019 - 02/2015
3	InterleukinsIBA 01/2018 - 07/2011
3	Thioacetamide (Thioacetamid)IBA 01/2016 - 07/2014
3	obeticholic acidIBA 01/2016 - 06/2014
2	Biological ProductsIBA 05/2022 - 12/2020
2	KynurenineIBA 01/2022 - 01/2019
2	Peptides (Polypeptides)IBA 01/2022 - 01/2019
2	Tryptophan (L-Tryptophan)FDA Link 01/2022 - 01/2019
2	Gemcitabine FDA Link 01/2022 - 01/2019
2	theasinensin AIBA 01/2022 - 01/2020
2	ApolipoproteinsIBA 01/2022 - 08/2015
2	Simvastatin (Zocor)FDA LinkGeneric 01/2022 - 01/2020

Therapy/Procedure

39	Therapeutics 08/2022 - 12/2009
37	Surgical Portasystemic Shunt (Portosystemic Shunt) 06/2022 - 11/2011
37	Transjugular Intrahepatic Portasystemic Shunt 06/2022 - 01/2013
19	Ligation 01/2021 - 02/2007
15	Liver Transplantation 08/2022 - 08/2009
12	Stents 10/2021 - 09/2015
4	Transplantation 08/2022 - 05/2017
3	Microspheres (Microsphere) 09/2019 - 06/2005
3	Secondary Prevention 09/2017 - 10/2010
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2019
2	Catheters 12/2021 - 01/2019